Ankylosing Spondylitis: Causes, Risk Factors, and Pathophysiology

Ankylosing Spondylitis (AS) is a chronic inflammatory arthritis primarily affecting the axial skeleton (spine, sacroiliac joints). It belongs to the spondyloarthritis (SpA) family. Etiology is multifactorial.

Genetic Factors

  • HLA-B27: Strongest association—present in 90–95% of AS patients (vs. 6–8% general population). Necessary but not sufficient—only 1–5% of HLA-B27+ individuals develop AS.
  • Other loci: ERAP1, IL23R, RUNX3, and >100 GWAS-identified variants contribute polygenic risk.
  • Family history: 1st-degree relatives have 10–20× increased risk.

Immunologic Pathophysiology

  • IL-23/IL-17 axis dysregulation: Central pathway. IL-23 drives Th17 cells → IL-17, IL-22, TNF-α → entheseal inflammation, osteoproliferation.
  • Enthesitis as primary lesion: Inflammation at ligament/tendon/bone insertion sites (entheses) → bone erosion → reactive new bone formation (syndesmophytes) → ankylosis (fusion).
  • Molecular mimicry hypothesis: Cross-reactivity between microbial antigens (e.g., Klebsiella) and HLA-B27/self-antigens—unproven but plausible.

Environmental Triggers (Hypothesized)

  • Gut microbiome dysbiosis (strong SpA-IBD link; 5–10% AS have clinical IBD, >50% subclinical gut inflammation).
  • Infections (GI, GU) may trigger onset in genetically susceptible.
  • Mechanical stress/trauma to entheses.
  • Smoking worsens severity and reduces treatment response.

What Does NOT Cause AS

  • Poor posture (may worsen symptoms, not cause disease).
  • Aging (onset typically 15–45; not wear-and-tear).
  • Lifestyle choices (diet, exercise don't cause AS, though they modify outcomes).

Clinical Red Flags for Referral

  • Chronic back pain >3 months, onset <45 years.
  • Improves with exercise, worsens with rest.
  • Morning stiffness >30 minutes.
  • Nocturnal pain (awakens from sleep).
  • Alternating buttock pain.
  • Associated: uveitis (acute anterior), psoriasis, IBD, enthesitis (Achilles, plantar fascia), dactylitis.

Diagnosis & Management

  • Imaging: X-ray (sacroiliitis grading), MRI (early active inflammation).
  • Labs: HLA-B27, CRP/ESR (often normal).
  • Treatment: NSAIDs first-line → TNF inhibitors / IL-17 inhibitors (biologics) → JAK inhibitors. PT/exercise essential.

Early rheumatology referral prevents irreversible structural damage.

Sprains - Related Articles